---
title: "GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286804657.md"
description: "Law Offices of Howard G. Smith is investigating GE HealthCare Technologies Inc. (GEHC) for potential violations of federal securities laws following a significant drop in share price after the company reported disappointing Q1 2026 results. Shareholders who lost money are encouraged to contact the law firm to discuss possible claims for recovery."
datetime: "2026-05-18T17:49:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286804657.md)
  - [en](https://longbridge.com/en/news/286804657.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286804657.md)
---

# GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

**GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation**

Law Offices of Howard G. Smith announces an investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company’s possible violations of federal securities laws.

**IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN GE HEALTHCARE TECHNOLOGIES INC. (GEHC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.**

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

**What Happened?**

On April 29, 2026, GE HealthCare reported its financial results for the first quarter of 2026. Among other items, GE HealthCare reported adjusted earnings per share of $0.99 and cut its full-year 2026 adjusted EPS guidance to a range of $4.80 to $5.00, down from prior guidance of $4.95 to $5.15.

During the associated earnings call, management disclosed “_**profit performance in the first quarter . . . was impacted by a recall associated with a PDx supplier**_” and that “_**\[y\] ear-over-year margin performance was also impacted by declines in PCS and the PDx supplier issue.**_”

On this news, the price of GE HealthCare shares declined by $9.01 per share, or 13.2%, to close at $59.49 per share on April 29, 2026.

**Contact Us To Participate or Learn More:**

If you purchased GE HealthCare securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:  
Law Offices of Howard G. Smith  
3070 Bristol Pike, Suite 112  
Bensalem, Pennsylvania 19020  
Telephone: (215) 638-4847  
Email: howardsmith@howardsmithlaw.com  
Visit our website at: www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Law Offices of Howard G. Smith  
Howard G. Smith, Esquire  
215-638-4847  
howardsmith@howardsmithlaw.com  
www.howardsmithlaw.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260518449223/en/

### Related Stocks

- [GEHC.US](https://longbridge.com/en/quote/GEHC.US.md)

## Related News & Research

- [Is Wall Street Bullish or Bearish on GE HealthCare Technologies Stock?](https://longbridge.com/en/news/286078986.md)
- [Watkin Phoebe Yang Buys 1,000 Shares of GE HealthCare Technologies (NASDAQ:GEHC) Stock](https://longbridge.com/en/news/286065488.md)
- [POET Technologies Announces Closing of US$400 Million Investment | POET Stock News](https://longbridge.com/en/news/286785400.md)
- [NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones | NTHI Stock News](https://longbridge.com/en/news/286931037.md)
- [GE Vernova Declares Third Quarter 2026 Dividend | GEV Stock News](https://longbridge.com/en/news/286966387.md)